Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019829 (Hodgkin's disease)
 30,247 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The authors report the results of the complex investigation of T-and B-lymphocytes in peripheral blood and functional features of T-cells in the reaction of blasttransformation with PHA in 27 patients with lymphogranulomatosis and in 30 healthy individuals. Generalized forms of lymphogranulomatosis of stage III-IV (in 21 of 27 patients) were predominating. All patients showed an active phase of the lesion. T-system immunity was found to be suppressed, that was manifested in reduced T-cells number, a decreased lymphocytes RBT to PHA per one or two dilutions. It is supposed that the observed T-lymphocytes disorders is one of the causes of the impairment of cell immunity reactions, found in vivo in patients with lymphogranulomatosis.
 ...
PMID:[T- and B-lymphocytes in lymphogranulomatosis]. 30 12

Under study were T- and B-systems of immunity in patients with lymphogranulomatosis, and these were correlated with clinical findings (the stage, intoxication, the effect of chemotherapy). Blastransformation reaction (RBT) with phytohemagglutinin (PHA), direct blasttransformation with sheep erythrocytes, immunofluorescence were estimated. The absolute amount of lymphocytes in 1 ml and also T- and B-cells were counted. Already in the stage I--II there was noted a reduction in the amount of T-lymphocytes and RBT to PHA. These changes in cell immunity were aggravated in the stage III B and stage IV B in particular. After the chemotherapy conducted according to the MOPP programme in most patients the immunological background would be more unfavourable. There was noted a relationship between the immune indice stability during chemotherapy for lymphogranulomatosis and the duration of remission.
 ...
PMID:[T- and B-lymphocyte changes in lymphogranulomatosis]. 38 Jan 55